Skip to content

Clinicall Research of Sarafua-Mask

Examination of safety and usefulness of hypoallergenic non-woven mask using ultrafine fibers - Examination of safety and usefulness of hypoallergenic non-woven mask

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044476
Enrollment
50
Registered
2021-07-31
Start date
2021-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mask dermatitis

Interventions

Hypoallergenic non-woven mask Brand name: Sarafua mask (Manufacturer: Kinsei Seishi) Regular product Non-woven mask Product name: Non-woven mask Normal size (Manufacturer: System Polymer Co., Ltd.)
Sarafua mask&quot
for 5 days, 2 days after that, and the group wearing the regular product mask for 5 days. The group wearing the regular product mask for 5 days, and 2 days later, the group wearing the &quot

Sponsors

Department of Dermatology, Kochi Medical school, Kochi University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Age 20 to 95 2) Written consent has been obtained from the individual to participate in this test.

Exclusion criteria

Exclusion criteria: 1) Subjects who are judged to be difficult to evaluate by the investigator or the coordinating doctor (those with dementia, those with allergies, those who cannot wear a mask)

Design outcomes

Primary

MeasureTime frame
Primary endpoint: Evaluation of skin symptoms (physician evaluation) Evaluation time: Before the start of the test, 5 days later, 11 days later Evaluation method: The degree of dryness is evaluated on a scale of (4) advanced, (3) moderate, (2) mild, (1) slight, and (0) none.

Secondary

MeasureTime frame
Secondary evaluation item: Questionnaire survey (subject evaluation) Evaluation time: Before, 5 days, 11 days after the start of the test

Countries

Japan

Contacts

Public ContactHideki Nakajima

Kochi Medical school, Kochi University Department of Dermatology

nakajima@kochi-u.ac.jp0888802363

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026